history of glp-1 Addressing patient concerns about the 'newness' and long-term safety GLP- 1 receptor agonists: A clinician's guide to counseling All About GLP-1s | BRMS

Results show broad benefits with a reduced risk of substance use and psychotic disorders, seizures, neurocognitive disorders (including Alzheimers disease and dementia), coagulation disorders, cardiometabolic disorders, infectious illnesses and several respiratory conditions

Numerous analysts have said the GLP-1s are very likely to disrupt certain areas of the MedTech industry, while others say MedTech can live side-by-side with the weight-loss drugs.1 In fact, the impact of GLP-1s is likely to be more nuanced than the blunt conclusions drawn by market watchers, with some companies and segments affected more than others

Boosts energy levels and enhances vitality

We've had a few enquiries about this "weight-loss" product this week

But their side effects often drive people to stop using them over the long term.

No, a pre-diabetic individual should not routinely take both metformin and a GLP-1 receptor agonist together, as current guidelines recommend against using G...